[{"data":1,"prerenderedAt":181},["ShallowReactive",2],{"drug-tamsulosin":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":36,"contraindications":62,"warnings":82,"renal":83,"monitoring":84,"interactions":85,"review":86,"examples":89,"atc":95,"iran":97,"links":117,"populations":134,"usApproval":176},"tamsulosin",1,{"fa":7,"en":8},"تامسولوسین","Tamsulosin","genitourinary-sex-hormones",{"fa":11,"en":12},"آلفا بلاکر","Alpha-1 blocker",[14],{"name":15,"market":16},"Flomax","US",[18,19,7,20],"flomax","فلوماکس","پروستات",[22],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":31,"refs":32},"cap-0-4","capsule","oral","0.4 mg capsule",{"amount":28,"unit":29,"perUnit":24,"scored":30},0.4,"mg",false,[16],[33],{"source":34,"section":35},"fda-tamsulosin","3",[37],{"id":38,"disease":38,"label":39,"population":42,"type":46,"unit":29,"dose":47,"refs":48,"limits":51,"notes":55},"bph",{"fa":40,"en":41},"BPH — ۰٫۴ mg یک بار در روز","BPH — 0.4 mg once daily",{"minAge":43},{"value":44,"unit":45},18,"year","fixed",{"perDose":28,"dosesPerDay":5},[49],{"source":34,"section":50},"2",{"maxPerDay":52,"refs":53},0.8,[54],{"source":34,"section":50},[56],{"text":57,"refs":60},{"fa":58,"en":59},"اگر پس از ۲ تا ۴ هفته پاسخ نبود ۰٫۸ mg. ۰٫۴ mg با مهارکننده‌های قوی CYP3A4 (کتوکونازول) مصرف نشود. اگر چند روز قطع شد، از ۰٫۴ از نو شروع شود.","If no response after 2–4 weeks, 0.8 mg. Do not use 0.4 mg with strong CYP3A4 inhibitors (ketoconazole). If interrupted several days, restart at 0.4.",[61],{"source":34,"section":50},[63,72],{"id":64,"severity":65,"text":66,"refs":69},"ci","block",{"fa":67,"en":68},"حساسیت به تامسولوسین.","Hypersensitivity to tamsulosin.",[70],{"source":34,"section":71},"4",{"id":73,"severity":65,"rule":74,"text":76,"refs":79},"child",{"maxAge":75},{"value":44,"unit":45},{"fa":77,"en":78},"برای کودکان اندیکاسیون ندارد.","Not indicated in pediatric populations.",[80],{"source":34,"section":81},"8.4",[],[],[],[],{"status":87,"reviewer":88,"date":88},"unverified",null,[90],{"regimen":38,"formulation":23,"input":91,"expect":94},{"ageYears":92,"weightKg":93},60,80,{"perDose":28},[96],"G04CA02",{"status":98,"forms":99,"refs":112},"registered",[100,104,108],{"code":101,"en":102,"fa":103},"05100","TAMSULOSIN 0.4MG CAP","کپسول تامسولوسین ۰٫۴ میلی‌گرم",{"code":105,"en":106,"fa":107},"01923","TAMSULOSIN 0.4MG TAB","قرص تامسولوسین ۰٫۴ میلی‌گرم",{"code":109,"en":110,"fa":111},"52331","TAMSULOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE ORAL 0.4 mg","قرص آهسته‌رهش تامسولوسین هیدروکلراید ۰٫۴ میلی‌گرم",[113],{"source":114,"section":115,"url":116},"darooyab-generic","G-1894\u002FTamsulosin","https:\u002F\u002Fwww.darooyab.ir\u002FG-1894\u002FTamsulosin",[118,122,126,129,132],{"kind":119,"url":120,"label":121},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=202433","ANDA202433",{"kind":123,"url":124,"label":125},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=f8302a6e-b8da-4931-a279-b49e37943816","FDA Tamsulosin",{"kind":127,"url":128,"label":8},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa698012.html",{"kind":130,"url":131,"label":96},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=G04CA02",{"kind":133,"url":116,"label":8},"darooyab",{"pregnancy":135,"lactation":144,"pediatric":152,"geriatric":160,"reproductive":168},{"level":136,"text":137,"quote":140,"refs":141},"caution",{"fa":138,"en":139},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary Tamsulosin hydrochloride is not indicated for use in women.",[142],{"source":34,"section":143},"8.1",{"level":136,"text":145,"quote":148,"refs":149},{"fa":146,"en":147},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Tamsulosin hydrochloride is not indicated for use in women.",[150],{"source":34,"section":151},"8.2",{"level":153,"text":154,"quote":157,"refs":158},"not-established",{"fa":155,"en":156},"برچسب: ایمنی و اثربخشی در کودکان ثابت نشده است.","Label: safety and effectiveness in children have not been established.","Tamsulosin hydrochloride capsules are not indicated for use in pediatric populations.",[159],{"source":34,"section":81},{"level":136,"text":161,"quote":164,"refs":165},{"fa":162,"en":163},"برچسب: در سالمندان با احتیاط و معمولاً از دوز پایین شروع شود.","Label: use with caution in older adults, usually starting at the low end of the dose range.","Of the total number of subjects (1783) in clinical studies of tamsulosin, 36% were 65 years of age and over.",[166],{"source":34,"section":167},"8.5",{"level":136,"text":169,"quote":172,"refs":173},{"fa":170,"en":171},"برچسب نکته‌ای درباره بارداری، پیشگیری یا باروری زنان و مردان دارد.","Label has advice on pregnancy testing, contraception or fertility for females and males.","Infertility Males Abnormal ejaculation including ejaculation failure, ejaculation disorder, retrograde ejaculation, and ejaculation decrease has been associated with tamsulosin hydrochloride [ see Clinical Trials Experience (6.1) ] .",[174],{"source":34,"section":175},"8.3",{"kind":177,"refs":178,"id":121},"ANDA",[179],{"source":34,"section":180},"SPL approval \u002F marketing category",1792444705269]